Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP789375.RABod-8J6pQtWHgmHVgpgl3Q-dwgKmWkYRLWzW6PwJARo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP789375.RABod-8J6pQtWHgmHVgpgl3Q-dwgKmWkYRLWzW6PwJARo130_assertion type Assertion NP789375.RABod-8J6pQtWHgmHVgpgl3Q-dwgKmWkYRLWzW6PwJARo130_head.
- NP789375.RABod-8J6pQtWHgmHVgpgl3Q-dwgKmWkYRLWzW6PwJARo130_assertion wasGeneratedBy ECO_0000203 NP789375.RABod-8J6pQtWHgmHVgpgl3Q-dwgKmWkYRLWzW6PwJARo130_provenance.
- NP789375.RABod-8J6pQtWHgmHVgpgl3Q-dwgKmWkYRLWzW6PwJARo130_assertion wasDerivedFrom befree-2016 NP789375.RABod-8J6pQtWHgmHVgpgl3Q-dwgKmWkYRLWzW6PwJARo130_provenance.
- NP789375.RABod-8J6pQtWHgmHVgpgl3Q-dwgKmWkYRLWzW6PwJARo130_assertion SIO_000772 20101208 NP789375.RABod-8J6pQtWHgmHVgpgl3Q-dwgKmWkYRLWzW6PwJARo130_provenance.
- NP789375.RABod-8J6pQtWHgmHVgpgl3Q-dwgKmWkYRLWzW6PwJARo130_assertion evidence source_evidence_literature NP789375.RABod-8J6pQtWHgmHVgpgl3Q-dwgKmWkYRLWzW6PwJARo130_provenance.
- NP789375.RABod-8J6pQtWHgmHVgpgl3Q-dwgKmWkYRLWzW6PwJARo130_assertion description "[We earlier identified a lysine to arginine transition at residue 303 (K303R) in estrogen receptor alpha (ERalpha) in invasive breast cancers, which confers resistance to the aromatase inhibitor (AI) anastrozole (Ana) when expressed in MCF-7 breast cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP789375.RABod-8J6pQtWHgmHVgpgl3Q-dwgKmWkYRLWzW6PwJARo130_provenance.